90691-40-0

Upstream product

• 13133-62-5 thiophenolate 
• 90691-39-7 (4'-fluoro-3,3',5-trimethyl<1,1'-biphenyl>-2-yl)methyl phenyl sulfide 
• 90691-38-6 2-(chloromethyl)-4'-fluoro-3,3',5-trimethyl-1,1'-biphenyl 
• 80617-38-5 4'-Fluoro-3,3',5-trimethyl[1,1'-biphenyl]-2-carboxaldehyde 
• 90691-37-5 2-(4-fluoro-3-methyl-phenyl)-4,6-dimethylbenzyl alcohol 

Downstream Products

• 100295-49-6 (2R,4R,6S)-(E)-6-<2-(4'-fluoro,3,3',5-trimethyl<1,1'-biphenyl>-2-yl)ethenyl>-4-(benzyloxy)-2-methoxy-3,4,5,6-tetrahydro-2H-pyran 
• 90691-43-3 (2S,4R,6S)-(E)-6-<2-(4'-fluoro-3,3',5-trimethyl<1,1'-biphenyl>-2-yl)ethenyl>-4-(benzyloxy)-2-methoxy-3,4,5,6-tetrahydro-2H-pyran 
• 90691-42-2 (2S,4R,6S)-1-(4'-fluoro-3,3',5-trimethyl<1,1'-biphenyl>-2-yl)-2-<4-(benzyloxy)-2-methoxy-3,4,5,6-tetrahydro-2H-pyran-6-yl>ethyl phenyl sulfoxide 

Relevant academic research and scientific papers

Synthesis and Utilization of the Chiral Synthon Methyl 3-O-Benzyl-2,4,6-trideoxy-6-iodo-α-D-erythro-hexopyranoside in the Synthesis of a Potent HMG-CoA Reductase Inhibitor

Synthesis of the potent HMG-CoA reductase inhibitor 1a has been achieved by utilizing the chiral synthon 2, which was prepared from methyl α-D-glucopyranoside in 12 steps (6 new).A key step in this sequence, which should have general applicability for the